SuperGen, Inc. To Present At UBS Global Pharmaceuticals Conference

DUBLIN, Calif., April 17 /PRNewswire-FirstCall/ -- SuperGen, Inc. today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the UBS Global Pharmaceuticals Conference, being held at the Grand Hyatt Hotel in New York City, on Monday, April 24, 2006 at 8:00 a.m. EDT. Dr. Manuso will provide a brief corporate overview and discuss the Company's recent progress.

A live webcast of Dr. Manuso's presentation will be available on the Investor Relations section of the Company's website at http://www.supergen.com. The webcast will be archived for 90 days.

About SuperGen

Based in Dublin, California, SuperGen is a pharmaceutical company dedicated to the discovery, acquisition, rapid development and commercialization of therapies for solid tumors, hematological malignancies and blood disorders. SuperGen's product portfolio includes: Nipent(R) (pentostatin for injection); Mitomycin (generic brand of Mutamycin(R)); and SurfaceSafe(R) cleaner.

For more information about SuperGen, please visit http://www.supergen.com. Contacts: SuperGen Noonan Russo Timothy L. Enns Sharon Weinstein S.V.P., Corporate Communications Director of Investor Relations & Business Development Tel: (925) 560-0100 x111 Tel: (212) 845-4271 E-mail: tenns@supergen.com E-mail: sharon.weinstein@eurorscg.com

SuperGen, Inc.

CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment of SuperGen, +1-925-560-0100 x111, tenns@supergen.com; orSharon Weinstein, Director of Investor Relations of Noonan Russo,+1-212-845-4271, sharon.weinstein@eurorscg.com

Back to news